An interventional study of Individualized Neurovisual Rehabilitation in Brain Injuries, sponsored by Charles University, Czech Republic. Not yet recruiting at 1 site in Czechia. Open to participants aged 18 Years to 85 Years. Per ClinicalTrials.gov, last updated 2026-09-30.
Sponsored by Charles University, Czech Republic · Not applicable, Interventional, and Treatment
This prospective single-group pilot study will evaluate the feasibility and preliminary outcomes of an individualized neurovisual rehabilitation program for adults with visual impairment following acquired brain injury.
Thirty participants will receive five individual therapist-led rehabilitation sessions together with individually prescribed self-training. The rehabilitation program will be tailored to each participant's identified visual impairment and functional difficulties.
Feasibility will be evaluated through intervention uptake, attendance, completion, adherence to prescribed self-training, and completion of post-intervention assessment. Preliminary changes in self-reported visual functioning and selected objective measures of visual function will be assessed from baseline to post-intervention.
Because the study has no control group, analyses of clinical outcomes will be exploratory and are not intended to provide definitive evidence of treatment efficacy.
Visual impairment following acquired brain injury may include oculomotor dysfunction, impaired visual attention and scanning, visual field loss, and other visual deficits that interfere with daily activities, mobility, and participation. Neurovisual rehabilitation may include restorative and compensatory approaches tailored to the individual's identified visual impairment and functional difficulties.
This prospective single-group pilot study will evaluate the feasibility and preliminary outcomes of an individualized neurovisual rehabilitation program in 30 adults with visual impairment following acquired brain injury.
Eligible participants will have at least one acquired visual impairment identified through standardized visual assessment and considered amenable to rehabilitation. Potential rehabilitation targets may include impaired fixation, smooth pursuit, saccadic eye movements, vergence, gaze stabilization, visual scanning and search, visual attention, and compensatory strategies for acquired visual field loss.
The intervention will consist of five individual therapist-led rehabilitation sessions, planned approximately once weekly. The period from the first to the final therapist-led session may extend to a maximum of 8 weeks to accommodate illness, scheduling difficulties, or other practical circumstances.
Treatment will be individualized according to the participant's identified visual impairment and functional difficulties. Participants will additionally receive individually prescribed self-training and will be instructed to perform self-training on at least 5 days per week between the first and final therapist-led rehabilitation sessions.
Intervention completion will be defined as completion of at least four of the five planned therapist-led sessions within 8 weeks. Full intervention completion will be defined as completion of all five sessions within this period.
The post-intervention assessment will be performed within 7 days after the participant's final completed therapist-led rehabilitation session, once the intervention period has been completed or discontinued.
The primary purpose of this pilot study is to evaluate feasibility. Feasibility outcomes will include intervention uptake, attendance, intervention completion, adherence to prescribed self-training, and completion of post-intervention assessment. Preliminary changes in self-reported visual functioning and selected objective measures of visual function will also be explored. Because this is an uncontrolled pilot study, analyses of clinical outcomes are exploratory and are not intended to provide definitive evidence of treatment efficacy.
Exclusion Criteria:
Inability to complete the study assessments or participate in the rehabilitation program because of severe cognitive, communication, behavioral, or medical limitations.
Participants will receive an individualized neurovisual rehabilitation program consisting of five individual therapist-led rehabilitation sessions together with individually prescribed self-training. Rehabilitation content will be selected according to each participant's identified visual impairment and functional difficulties.
Behavioral: Individualized Neurovisual Rehabilitation
Individualized neurovisual rehabilitation will be delivered in five individual therapist-led sessions, planned approximately once weekly and completed within a maximum period of 8 weeks from the first therapist-led session. Treatment content will be selected according to each participant's identified visual impairment and functional difficulties and may include training of fixation, smooth pursuit, saccadic eye movements, vergence, gaze stabilization, visual scanning and search, visual attention, and compensatory strategies for acquired visual field loss. Participants will additionally receive individually prescribed self-training and will be instructed to perform self-training on at least 5 days per week between the first and final therapist-led rehabilitation sessions.
Intervention completion
Proportion of participants who complete at least four of the five planned individual therapist-led neurovisual rehabilitation sessions within a maximum period of 8 weeks from the first therapist-led session. Intervention completion is defined as attendance at at least four of the five planned therapist-led sessions within this period. Completion of all five planned sessions within 8 weeks will additionally be recorded as full intervention completion. The outcome will be reported as the number and proportion of enrolled participants meeting the intervention completion criterion.
Time frame: From the first therapist-led rehabilitation session through 8 weeks
Change in self-reported functional visual performance measured by the R-SRAFVP
Change from baseline in self-reported functional visual performance assessed using the Revised Self-Report Assessment of Functional Visual Performance (R-SRAFVP). The R-SRAFVP consists of 33 items assessing vision-dependent daily activities. Applicable items are rated on a 5-point scale from 0 (unable; dependent on others to perform the task) to 4 (independent; no difficulty performing the task safely, accurately, and efficiently). Items that are not applicable to the participant may be rated as not applicable (NA). The R-SRAFVP score calculated according to the standardized scoring procedure will be used for the pre-post comparison. Higher item ratings indicate greater independence and less difficulty in performing vision-dependent daily activities.
Time frame: Baseline and within 7 days after the participant's final completed therapist-led rehabilitation session
Change in visual attention and scanning performance
Change from baseline in visual attention and visual scanning performance, assessed using selected visual search subtests of the Brain Injury Visual Assessment Battery for Adults (biVABA). The same selected subtests will be administered at baseline and post-intervention. Performance will be evaluated using task-specific measures, including percentage of correct responses, completion time in seconds, and organization of the visual search strategy, as applicable to the respective subtest. At least one structured and one unstructured visual search subtest will be used for repeated assessment. Outcomes for individual subtests and performance parameters will be evaluated separately; no composite biVABA visual attention score will be calculated.
Time frame: Baseline and within 7 days after the participant's final completed therapist-led rehabilitation session
Change in oculomotor function
Change from baseline in oculomotor findings assessed using the oculomotor assessments of the Brain Injury Visual Assessment Battery for Adults (biVABA). The assessment will include fixation, smooth pursuit, saccadic eye movements, ocular alignment, and vergence, as applicable to the participant. Pre-post changes will be evaluated separately for the oculomotor functions assessed using the findings and performance criteria specified for the respective biVABA assessments. No composite oculomotor score will be calculated.
Time frame: Baseline and within 7 days after the participant's final completed therapist-led rehabilitation session
Change in visual field findings assessed by Damato campimetry
Change from baseline in central visual field findings assessed using the Damato 30-Point Multifixation Campimeter included in the Brain Injury Visual Assessment Battery for Adults (biVABA). At each tested visual field location, failure to detect the presented target will be recorded on the visual field diagram according to the standardized biVABA procedure. Baseline and post-intervention visual field findings will be compared with respect to the location and extent of missed target locations and the resulting visual field deficit pattern. No composite visual field score will be calculated.
Time frame: Baseline and within 7 days after the participant's final completed therapist-led rehabilitation session
Uptake of the neurovisual rehabilitation study
Proportion of individuals who meet the eligibility criteria for the interventional study and consent to participate. Uptake will be calculated as the number of eligible individuals who provide informed consent and enroll in the interventional study divided by the total number of eligible individuals invited to participate.
Time frame: From determination of eligibility through enrollment in the interventional study
Attendance at therapist-led rehabilitation sessions
Number of individual therapist-led neurovisual rehabilitation sessions attended by each participant out of the five planned sessions. Attendance will be reported as the number of sessions attended and as the proportion of the five planned therapist-led sessions completed by each participant.
Time frame: From the first therapist-led rehabilitation session through 8 weeks
Adherence to prescribed self-training
Adherence to individually prescribed self-training during the neurovisual rehabilitation program. Participants will be instructed to perform self-training at least 5 days per week between the first and final therapist-led rehabilitation sessions. Adherence will be calculated for each participant as the number of self-training days reported as completed divided by the number of self-training days prescribed, expressed as a percentage.
Time frame: From the first through the final therapist-led rehabilitation session, up to 8 weeks
Completion of post-intervention assessment
Proportion of enrolled participants who complete the planned post-intervention assessment. The post-intervention assessment will be performed within 7 days after the participant's final completed therapist-led rehabilitation session, once the intervention period has been completed or discontinued. The outcome will be reported as the number and proportion of enrolled participants who complete the post-intervention assessment within the specified time frame.
Time frame: From enrollment through completion of the post-intervention assessment
Plan to share: No — Individual participant data are not planned to be made publicly available or shared with other researchers. Study results will be disseminated in aggregated and de-identified form through scientific publications and presentations. No individual participant data sharing plan has been established for this study.
No publications or documents are linked to this record.
This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Charles University, Czech Republic